Millions of Americans who have allergies have really had only one option when it comes to emergency treatment for a severe reaction: using an autoinjector like the EpiPen. But now there's an ...

Those who rely on EpiPens during an allergic reaction may have a new alternative to reach for, after the U.S. Food and Drug Administration (FDA) approved Neffy, a needle-free epinephrine product.

CVS (operating in Hawaii as Longs Drugs) is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment ...

An alternative to epinephrine autoinjectors that can be delivered by a nasal spray is close to approval in Europe after being recommended for approval by the EMA’s human medicines committee.

There's a very good reason why the EpiPen's 500% price increase drew so much attention, even though there are other emergency auto-injecting devices available that can be used to treat severe ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS Pharmaceuticals received the green light from health regulators for a ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS Pharmaceuticals received the green light from health regulators for a ...

Viatris Inc., formerly called Mylan, settled a class action lawsuit alleging that they were in a scheme to monopolize the market for the life-saving medication Julie Mazziotta is the Senior Sports ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS Pharmaceuticals received the green light from health regulators for a ...